Health
Study sheds light on reduced neutralization of SARS-CoV-2 variants of concern – News-Medical.Net
Researchers in the United States have predicted the binding epitopes of uncharacterized neutralizing antibodies that target the receptor-binding domain (RBD) of…
Researchers in the United States have predicted the binding epitopes of uncharacterized neutralizing antibodies that target the receptor-binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
The novel SARS-CoV-2 virus is the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic that continues to pose a threat to global public health and the economy worldwide.
The spike protein mediates the first stage of the SARS-CoV-2 infection…
-
Noosa News24 hours agoMeasles alert issued across popular south-east attractions
-
General24 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
Noosa News22 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
General17 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts